Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Chelsea Therapeutics International Ltd.    CHTP   US1634281059

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancials 
Company
Chelsea Therapeutics International Ltd. is a development stage biopharmaceutical company, which seeks to acquires, develops and commercializes innovative products for the treatment of a variety of human diseases, including central nervous system disorders.The company product includes... 
More about the company
Chart CHELSEA THERAPEUTICS INTER
Duration : Period :
Chelsea Therapeutics Inter Technical Analysis Chart | CHTP | US1634281059 | 4-Traders
Full-screen chart
Latest news on CHELSEA THERAPEUTICS INTER
2014 H LUNDBECK A/S : Lundbeck Acquires Chelsea Therapeutics
2014 CHELSEA THERAPEUTICS : Lundbeck Purchases Chelsea Therapeutics International
2014 H LUNDBECK A/S : Lundbeck Buys Chelsea Therapeutics
2014 CHELSEA THERAPEUTICS : Lundbeck Acquires Chelsea Therapeutics International
2014 CHELSEA THERAPEUTICS : Notice of Delisting or Failure to Satisfy a Continued Lis..
2014 CHELSEA THERAPEUTICS : Lundbeck successfully completes tender offer for Chelsea ..
2014 CHELSEA THERAPEUTICS : NORTHERA(TM) Clinical Trial Data Published in Neurology
2014 Chelsea Therapeutics Presents Efficacy and Safety Data for NORTHERA at Intern..
More news
Sector news Bio Therapeutic Drugs
01/30 PHARMACYCLICS : Johnson & Johnson: U.S. FDA Approves IMBRUVICA (ibrutinib) for t..
01/29DJValeant to Buy Prostate-Cancer Drug From Dendreon
01/29DJValeant in Deal to Buy Prostate-Cancer Drug Provenge From Dendreon
Plus d'actualités du secteur Bio Therapeutic Drugs


Comments 
Advertisement
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF